切换至 "中华医学电子期刊资源库"
高级检索
中华肝脏外科手术学电子杂志

中华肝脏外科手术学电子杂志 ›› 2017, Vol. 06 ›› Issue (01) : 34 -39. doi: 10.3877/cma.j.issn.2095-3232.2017.01.008

所属专题： 文献；

临床研究

复发性肝细胞癌再次手术切除与射频消融临床疗效比较的Meta分析
陈曦1, 刘鹏2, 张贤彬2, 闫玉梅2, 巩鹏2,†()   
  1. 1. 256603　山东省滨州医学院附属医院急诊科
    2. 116000　大连医科大学附属第一医院肝胆外科
  • 收稿日期:2016-10-22 出版日期:2017-02-10
  • 通信作者: 巩鹏
  • 基金资助:
    国家自然科学基金(81473504)

Comparison of clinical efficacy between surgical re-resection and radiofrequency ablation for recurrent hepatocellular carcinoma: a Meta-analysis

Xi Chen1, Peng Liu2, Xianbin Zhang2, Yumei Yan2, Peng Gong2,†()   

  1. 1. Department of Emergency, Binzhou Medical University Hospital, Binzhou 256603, China
    2. Department of Hepatobiliary Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian 116000, China
  • Received:2016-10-22 Published:2017-02-10
  • Corresponding author: Peng Gong
  • About author:
    Corresponding author: Gong Peng, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

陈曦, 刘鹏, 张贤彬, 闫玉梅, 巩鹏. 复发性肝细胞癌再次手术切除与射频消融临床疗效比较的Meta分析[J]. 中华肝脏外科手术学电子杂志, 2017, 06(01): 34-39.

Xi Chen, Peng Liu, Xianbin Zhang, Yumei Yan, Peng Gong. Comparison of clinical efficacy between surgical re-resection and radiofrequency ablation for recurrent hepatocellular carcinoma: a Meta-analysis[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2017, 06(01): 34-39.

目的

探讨再次手术切除（SRR）与射频消融（RFA）治疗复发性肝细胞癌（肝癌）的临床疗效差别。

方法

计算机检索2010年1月至2016年1月Medline、PubMed、Cochrane、CNKI、CBM、万方、维普等数据库。英文检索词：hepatocellular carcinoma、hepatic carcinoma、liver cancer、liver neoplasms、HCC、recurrent、recurrence、relapse、recurring、resection、hepatectomy、radio frequency ablation、ablation、radio frequency、radio-frequency、RFA、PRFA。中文检索词：肝癌、肝细胞癌、肝肿瘤、复发、手术、射频消融。将患者分为SRR组和RFA组，对两组术后3年生存率、3年无瘤生存率、3年复发率、并发症发生率、住院时间等结局指标进行Meta分析。

结果

共有8篇文献，856例患者纳入本研究。其中随机对照实验1篇，回顾性分析文献7篇。Meta分析结果显示，两组3年生存率差异无统计学意义（OR=1.02，95%CI：0.75～1.39；P>0.05）。SSR组3年无瘤生存率优于RFA组（OR=1.63，95%CI：1.05～2.54；P<0.05）。两组3年复发率差异无统计学意义（OR=0.85，95%CI：0.48～1.49；P>0.05）。SRR组术后Clavien Ⅱ级以上并发症发生率明显高于RFA组（OR=13.33，95%CI：2.43～73.06；P<0.05）。SRR组住院时间明显长于RFA组（SMD=5.23，95%CI：2.85～7.61；P<0.05）。

结论

对于复发性肝癌的治疗，两种治疗方法的总体生存率无明显差异，但SRR治疗的无瘤生存率优于RFA。RFA具有临床安全性相对较高、住院时间较短等优势。

关键词: 癌，肝细胞, 再手术, 导管消融术, Meta分析
Objective

To compare the difference of clinical efficacy between surgical re-resection (SRR) and radiofrequency ablation (RFA) for recurrent hepatocellular carcinoma (HCC).

Methods

Literature from the databases Medline, PubMed, Cochrane, CNKI, CBM, Wangfang and VIP between January 2010 and January 2016 was searched. The English keywords were hepatocellular carcinoma, hepatic carcinoma, liver cancer, liver neoplasms, HCC, recurrent, recurrence, relapse, recurring, resection, hepatectomy, radio frequency ablation, ablation, radio frequency, radio-frequency, RFA and PRFA. And the Chinese keywords were liver cancer, hepatocellular carcinoma, liver neoplasms, recurrence, surgery and RFA. The patients were divided into the SRR group and RFA group. The outcome indicators including the 3-year survival rate, 3-year tumor-free survival rate, 3-year recurrence rate, incidence of complications and length of hospital stay after surgery of two groups were analyzed using Meta-analysis.

Results

A total of 8 literatures, 856 patients were included in this study, including 1 randomized controlled trial and 7 retrospective studies. The Meta-analysis results revealed that no significant difference was observed in the 3-year survival rate between two groups (OR=1.02, 95%CI: 0.75-1.39, P>0.05). The 3-year tumor-free survival rate in the SSR group was significantly higher than that in the RFA group (OR=1.63, 95%CI: 1.05-2.54, P<0.05). No significant difference was observed in the 3-year recurrence rate between two groups (OR=0.85, 95%CI: 0.48-1.49, P>0.05). The incidence of complications above Clavien grade Ⅱ after surgery in the SRR group was significantly higher than that in the RFA group (OR=13.33, 95%CI: 2.43-73.06, P<0.05). The length of hospital stay in the SRR group was significantly longer than that in the RFA group (SMD=5.23, 95%CI: 2.85-7.61, P<0.05).

Conclusions

For the treatment of recurrent HCC, there is no significant difference in the overall survival rate between SRR and RFA, but the tumor-free survival rate in the SRR group is significantly higher than that in the RFA group, whereas RFA has the advantages of higher safety and shorter length of hospital stay.

Key words: Carcinoma, hepatocellular, Reoperation, Catheter ablation, Meta-analysis
表1 复发性肝细胞癌再次手术切除与射频消融疗效Meta分析入选文献基本信息
作者 年份 例数 平均年龄（岁） 性别比（男∶女） 肿瘤直径（cm）
SRR RFA SRR RFA
罗嘉等[8] 2011 47 - 21∶3 021∶2 - -
董晓刚等[9] 2011 63 52 16∶2 012∶5 - -
梁惠宏等[10] 2011 151 63 65∶7 069∶10 2.16±0.10 2.46±0.10
张辉等[11] 2013 168 - - - 3.50 2.10
黄新辉等[12] 2013 112 52 51∶15 036∶10 2.90±1.10 2.60±0.90
吴斌等[13] 2014 60 60±6 38∶22 - 4.30±0.82 -
张婷婷等[14] 2014 66 50±13 25∶2 037∶2 3.20±1.00 2.70±1.10
Song等[15] 2015 217 55 31∶8 145∶33 2.20±1.10 1.70±0.60
图1 SRR组与RFA组复发性肝细胞癌患者3年生存率的Meta分析森林图
图2 SRR组与RFA组复发性肝细胞癌患者3年无瘤生存率的Meta分析森林图
图3 SRR组与RFA组复发性肝细胞癌患者3年复发率的Meta分析森林图
图4 SRR组与RFA组复发性肝细胞癌患者Clavien Ⅱ级以上并发症发生率的Meta分析森林图
图5 SRR组与RFA组复发性肝细胞癌患者住院时间的Meta分析森林图
[1]
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2):87-108.
[2]
Bruix J, Sherman M. Management of hepatocellular carcinoma: an update[J]. Hepatology, 2013, 53(3):1020-1022.
[3]
Roayaie S, Obeidat K, Sposito C, et al. Resection of hepatocellular cancer≤2 cm: results from two Western centers[J]. Hepatology, 2013, 57(4):1426-1435.
[4]
Cheung TT, Poon RT, Yuen WK, et al. Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience[J]. Ann Surg, 2013, 257(3):506-511.
[5]
Shrager B, Jibara G, Schwartz M, et al. Resection of hepatocellular carcinoma without cirrhosis[J]. Ann Surg, 2012, 255(6):1135-1143.
[6]
N'Kontchou G, Mahamoudi A, Aout M. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis[J]. Hepatology, 2009, 50(5):1475-1483.
[7]
Chu KK, Cheung TT. Update in management of hepatocellular carcinoma in Eastern population[J]. World J Hepatol, 2015, 7(11):1562-1571.
[8]
罗嘉，吴飞跃，汤明．复发性小肝癌再次手术和消融栓塞治疗的探讨[J]．中国普通外科杂志，2011, 20(7): 676-679.
[9]
董晓刚，卓越，李海军，等．复发性小肝癌再次手术与射频消融的临床分析[J]．兵团医学，2011, 30(4): 7-9.
[10]
梁惠宏，彭振维，陈敏山，等．经皮射频消融与再手术治疗单个直径≤3cm的复发性肝癌的疗效比较[J]．中华消化外科杂志，2011, 10(1): 36-39.
[11]
张辉，徐新保，何晓军，等．原发性肝癌术后复发再手术切除与射频消融治疗的疗效比较[J]．西部医学，2013, 25(12): 1816-1818.
[12]
黄新辉，黄尧，林科灿，等．复发性小肝细胞癌射频消融与再手术切除疗效的分析[J]．腹部外科，2013, 26(2): 93-95.
[13]
吴斌．原发性肝癌复发射频消融与手术治疗疗效分析[J]．中国处方药，2014, 12(11): 104, 122.
[14]
张婷婷，李开艳，罗鸿昌，等．经皮微波消融和二次手术治疗晚期复发型小肝癌的长期疗效观察[J]．中华医学杂志，2014, 94(33): 2570-2572.
[15]
Song KD, Lim HK, Rhim H, et al. Repeated hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma after hepatic resection: a propensity score matching study[J]. Radiology, 2015, 275(2): 599-608.
[16]
Troisi RI, Patriti A, Montalti R, et al. Robot assistance in liver surgery: a real advantage over a fully laparoscopic approach? results of a comparative bi-institutional analysis[J]. Int J Med Robot, 2013, 9(2):160-166.
[17]
Lai EC, Tang CN, Yang GP, et al. Multimodality laparoscopic liver resection for hepatic malignancy--from conventional total laparoscopic approach to robot-assisted laparoscopic approach[J]. Int J Surg, 2011, 9(4):324-328.
[18]
Ji WB, Wang HG, Zhao ZM, et al. Robotic-assisted laparoscopic anatomic hepatectomy in China: initial experience[J]. Ann Surg, 2011, 253(2):342-348.
[19]
Chan AC, Poon RT, Cheung TT, et al. Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma[J]. World J Surg, 2012, 36(1):151-156.
[20]
王峰杰，陈焕伟，甄作均，等．腹腔镜射频消融术在治疗复杂肝细胞癌中的应用[J/CD]．中华肝脏外科手术学电子杂志，2016, 5(5): 304-307.
[21]
孙文兵，丁雪梅，高君，等．提升肝细胞癌射频消融疗效的技术性措施：外科视角[J]．中华肝胆外科杂志，2011, 17(7): 534-538.
[22]
Yang B, Zou J, Xia J, et al. Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation[J]. Eur J Radiol, 2011, 79(2):196-200.
[23]
Yamashita S, Aoki T, Inoue Y, et al. Outcome of salvage hepatic resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy[J]. Surgery, 2015, 157(3):463-472.
[24]
Thomasset SC, Dennison AR, Garcea G. Ablation for recurrent hepatocellular carcinoma: a systematic review of clinical efficacy and prognostic factors[J]. World J Surg, 2015, 39(5):1150-1160.
[25]
Ng KK, Lo CM, Liu CL, et al. Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplant[J]. Arch Surg, 2008, 143(1):68-74.
[26]
许继凡，戴珏，郭涛，等．再次肝切除治疗复发性肝癌疗效及预后因素分析[J]．中国普通外科杂志，2014, 23(7):873-877.
[27]
孙鋆泽，陆华虎，吕凌，等．影响肝癌术后复发危险因素的研究进展[J/CD]．中华临床医师杂志(电子版)，2011, 5(11):3245-3249.
[28]
Mundeleer L, Wikler D, Leloup T, et al. Development of a computer assisted system aimed at RFA liver surgery[J]. Comput Med Imaging Graph, 2008, 32(7):611-621.
[1] 张思平, 刘伟, 马鹏程. 全膝关节置换术后下肢轻度内翻对线对疗效的影响[J]. 中华关节外科杂志(电子版), 2023, 17(06): 808-817.
[2] 罗旺林, 杨传军, 许国星, 俞建国, 孙伟东, 颜文娟, 冯志. 开放性楔形胫骨高位截骨术不同植入材料的Meta分析[J]. 中华关节外科杂志(电子版), 2023, 17(06): 818-826.
[3] 李雄雄, 周灿, 徐婷, 任予, 尚进. 初诊导管原位癌伴微浸润腋窝淋巴结转移率的Meta分析[J]. 中华普通外科学文献(电子版), 2023, 17(06): 466-474.
[4] 张再博, 王冰雨, 焦志凯, 檀碧波. 胃癌术后下肢深静脉血栓危险因素的Meta分析[J]. 中华普通外科学文献(电子版), 2023, 17(06): 475-480.
[5] 莫闲, 杨闯. 肝硬化患者并发门静脉血栓危险因素的Meta分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 678-683.
[6] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[7] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[8] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[9] 段文忠, 白延霞, 徐文亭, 祁虹霞, 吕志坚. 七氟烷和丙泊酚在肝切除术中麻醉效果比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 640-645.
[10] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[11] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[12] 张维志, 刘连新. 基于生物信息学分析IPO7在肝癌中的表达及意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 694-701.
[13] 陈安, 冯娟, 杨振宇, 杜锡林, 柏强善, 阴继凯, 臧莉, 鲁建国. 基于生物信息学分析CCN4在肝细胞癌中表达及其临床意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 702-707.
[14] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[15] 吴晨瑞, 廖锐, 贺强, 潘龙, 黄平, 曹洪祥, 赵益, 王永琛, 黄俊杰, 孙睿锐. MDT模式下肝动脉灌注化疗联合免疫靶向治疗肝细胞癌多处转移一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 713-716.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号